Drug profile · INN
topiramate
TOPIRAMATE
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
topiramate (TOPIRAMATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 11969470
Topiramate compositions and methods of making and using the same
granted -
US 11071787
Topiramate compositions and methods of making and using the same
granted -
US 10314790
Sustained-release formulations of topiramate
granted -
US 9744137
Topiramate compositions and methods of enhancing its bioavailability
granted -
US 9622983
Sustained-release formulations of topiramate
granted -
US 9555004
Sustained-release formulations of topiramate
granted -
US 9549940
Sustained-release formulations of topiramate
granted -
US 8992989
Sustained-release formulations of topiramate
granted
Frequently asked questions
What is topiramate?
topiramate (TOPIRAMATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for topiramate?
TOPIRAMATE is a marketed brand name for topiramate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of topiramate?
topiramate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.